Correlation Between TG Therapeutics and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Biomarin Pharmaceutical, you can compare the effects of market volatilities on TG Therapeutics and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Biomarin Pharmaceutical.
Diversification Opportunities for TG Therapeutics and Biomarin Pharmaceutical
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between TGTX and Biomarin is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between TG Therapeutics and Biomarin Pharmaceutical
Given the investment horizon of 90 days TG Therapeutics is expected to generate 3.81 times more return on investment than Biomarin Pharmaceutical. However, TG Therapeutics is 3.81 times more volatile than Biomarin Pharmaceutical. It trades about 0.34 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.28 per unit of risk. If you would invest 2,313 in TG Therapeutics on August 24, 2024 and sell it today you would earn a total of 1,142 from holding TG Therapeutics or generate 49.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
TG Therapeutics vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| TG Therapeutics |
| Biomarin Pharmaceutical |
TG Therapeutics and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with TG Therapeutics and Biomarin Pharmaceutical
The main advantage of trading using opposite TG Therapeutics and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |